Hamdy Sayed
Overview
Explore the profile of Hamdy Sayed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shousha H, Barakat E, Rewisha E, El-Kassas M, Moustafa E, Said M, et al.
Arab J Gastroenterol
. 2025 Jan;
26(1):94-103.
PMID: 39794187
Background And Study Aims: Few studies have considered patients treated with trans-arterial chemoembolization (TACE) for non-viral-induced hepatocellular carcinoma (HCC), with some reporting that those patients may have larger tumors, emphasizing...
2.
El-Kassas M, Barakat E, Shousha H, Kohla M, Said M, Moustafa E, et al.
Eur J Gastroenterol Hepatol
. 2024 Dec;
37(1):83-93.
PMID: 39621880
Background: Viral hepatitis B and C are the leading causes of hepatocellular carcinoma (HCC). With obesity, metabolic-related disorders are increasingly associated with a higher incidence of nonviral HCC. This study...
3.
Madkour A, Elfouly A, Gamal M, Ghanem A, Sayed H, Atalla H
Gastrointest Endosc
. 2024 Aug;
101(1):213-214.
PMID: 39089600
No abstract available.
4.
Madkour A, Elfouly A, Sayed H, El-Tawansy A, Tawheed A, Atalla H
Endoscopy
. 2024 Feb;
56(S 01):E118-E119.
PMID: 38307116
No abstract available.
5.
El-Kassas M, Sayed H, Omran D, Eldahrouty A, Elbaz T, Kamal E
Asian Pac J Cancer Prev
. 2023 Feb;
24(2):597-605.
PMID: 36853310
Background & Aims: The safety and efficacy of hepatitis C (HCV) direct-acting antivirals (DAAs) have been established in several real-world trials; however, some reports have claimed an association between DAAs...
6.
El-Kassas M, El Gaafary M, Elbadry M, Medhat M, Dabbous H, Hassan E, et al.
J Infect Dev Ctries
. 2022 Jul;
16(7):1138-1147.
PMID: 35905018
Introduction: COVID-19 severity and mortality predictors could determine admission criteria and reduce mortality. We aimed to evaluate the clinical-laboratory features of hospitalized patients with COVID-19 to develop a novel score...
7.
Medhat M, El-Kassas M, Karam-Allah H, Al Shafie A, Abd-Elsalam S, Moustafa E, et al.
Arab J Gastroenterol
. 2022 Jun;
23(3):165-171.
PMID: 35690556
Background And Study Aims: Currently, there is no therapy approved for COVID-19. We evaluated the efficacy and safety of sofosbuvir/ledipasvir and nitazoxanide for the treatment of patients with COVID-19 infection....
8.
Kassas M, Asem N, Abdelazeem A, Madkour A, Sayed H, Tawheed A, et al.
J Infect Dev Ctries
. 2020 Dec;
14(12):1352-1360.
PMID: 33378275
Introduction: The recently discovered novel coronavirus disease (COVID-19) has emerged in Wuhan, China, since January 2020. Egypt reported a low incidence of infection when compared with other countries. The aim...